Wound Management Technologies Inc Share Price Other OTC
Equities
US98211X1063
Pharmaceuticals
Sales 2024 * | 77.3M 6.45B | Sales 2025 * | 88.6M 7.39B | Capitalization | 239M 19.94B |
---|---|---|---|---|---|
Net income 2024 * | -6M -501M | Net income 2025 * | -1M -83.45M | EV / Sales 2024 * | 3.09 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
-35.1
x | P/E ratio 2025 * |
-252
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.54% |
Latest transcript on Wound Management Technologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 11/18/11 |
Chief Tech/Sci/R&D Officer | - | 01/23/01 | |
Chief Tech/Sci/R&D Officer | 39 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 01/22/01 |
Roszell Mack
BRD | Director/Board Member | 57 | 01/22/01 |
Eric Major
BRD | Director/Board Member | 55 | 01/23/01 |
1st Jan change | Capi. | |
---|---|---|
+55.64% | 816B | |
+39.65% | 634B | |
-7.41% | 351B | |
+15.91% | 323B | |
+7.07% | 293B | |
+13.42% | 238B | |
+0.70% | 222B | |
+13.36% | 218B | |
+8.01% | 167B |